GlassScriptPhysician profile
Ayman A Hamed
NPI 1235162165
$7,369.10
in general payments reported to CMS, 2019-2025
25 companies · $4,423 in 2025
The $4,423 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $229 · 2021: $424 · 2022: $119 · 2023: $373 · 2024: $1,617 · 2025: $4,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,484 · Travel and Lodging: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,484.21 |
| Travel and Lodging | $1,929.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $3,422.57 | 2024-2025 | Evoke |
| Si-Bone, INC. | $724.30 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $458.13 | 2023-2025 | Relistor |
| Nevro Corp. | $445.40 | 2021-2024 | Senza |
| Spinal Simplicity, LLC | $330.57 | 2025 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $288.56 | 2025 | Prospera |
| Medtronic, INC. | $241.25 | 2021-2025 | Synchromedii, Inceptiv |
| Ibsa Pharma INC. | $205.49 | 2021-2023 | Licart, Tirosint |
| Biodelivery Sciences International, INC. | $198.67 | 2019-2021 | |
| Abbott Laboratories | $139.21 | 2019-2023 | Proclaim |
| Medtronic USA, INC. | $127.72 | 2020 | |
| Collegium Pharmaceutical, INC. | $115.54 | 2024-2025 | Belbuca |
| Forte Bio-Pharma LLC | $108.74 | 2022-2024 | Prolate, Nalocet |
| Virtus Pharmaceuticals LLC | $97.51 | 2023-2025 | Levorphanol Tartrate |
| Curonix LLC | $90.60 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Stimwave Technologies Incorporated | $65.93 | 2021 | |
| Pfizer INC. | $53.10 | 2020-2021 | |
| Valinor Pharma, LLC | $51.33 | 2024-2025 | Movantik |
| Lundbeck LLC | $40.12 | 2025 | Vyepti |
| Boston Scientific Corporation | $26.70 | 2019-2021 | |
| Redhill Biopharma INC. | $17.51 | 2020 | |
| Azurity Pharmaceuticals, INC. | $15.91 | 2024 | Horizant |
| Daiichi Sankyo INC. | $14.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Hamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.